Telomir Pharmaceuticals Stock Quote TELO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

6.65

Bid

6.65

Ask

7.04

Volume

360,215

5.75 Day's Range 7.0791

3.11 52 Week Range 20.72

Market Cap

196.905M

Previous Close

5.57

Open

5.76

Last Trade

100

6.65

(formt)

Last Trade Time

Financial Volume

$ 2,370,545

VWAP

6.5809

Average Volume (3m)

146,862

Shares Outstanding

29,609,814

Dividend Yield

PE Ratio

-14.68

Earnings Per Share (EPS)

-0.44

Revenue

Net Profit

-13.07M

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new t... Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new treatment options for age-related inflammatory conditions, with hemochromatosis as its initial clinical focus, and to thereafter expand the development of TELOMIR-1 to post-chemotherapy recovery as well as a broader range of other age-related inflammatory diseases and conditions such as osteoarthritis. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.telomirpharma.com

Headquarters

Tampa, Florida, USA

Founded

Telomir Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TELO. The last closing price for Telomir Pharmaceuticals was $5.57. Over the last year, Telomir Pharmaceuticals shares have traded in a share price range of $ 3.11 to $ 20.72.

Telomir Pharmaceuticals currently has 29,609,814 shares outstanding. The market capitalization of Telomir Pharmaceuticals is $164.93 million. Telomir Pharmaceuticals has a price to earnings ratio (PE ratio) of -14.68.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

Telomir Board of Directors appoints Erez Aminov as CEO and Chairman of the Board Telomir also announces Board of Directors departures and additions TAMPA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE...

Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development...

Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

TAMPA, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development...

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

Commences the study, The Safety of Telomir-1 when Administered Orally to Geriatric Laboratory Beagle Dogs for 63 Consecutive Days study to evaluate the safety of Telomir-1 on geriatric canines...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.35	54.6511627907	4.3	7.04	3.945	275593	4.83028007	CS
4	2.54	61.800486618	4.11	7.04	3.198	174284	4.4809117	CS
12	0.74	12.5211505922	5.91	8.4	3.198	146862	5.61305717	CS
26	1.5	29.1262135922	5.15	8.4	3.11	106513	5.47600142	CS
52	-0.35	-5	7	20.72	3.11	86902	6.09555024	CS
156	-0.35	-5	7	20.72	3.11	86902	6.09555024	CS
260	-0.35	-5	7	20.72	3.11	86902	6.09555024	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UPCUniverse Pharmaceuticals Inc	$ 3.38 (221.90%)	93.61M
LIFWMSP Recovery Inc	$ 3.2461 (104.16%)	29.02M
GXAIGaxos ai Inc	$ 2.5801 (81.70%)	145.81M
SBETSharpLink Gaming Inc	$ 0.9116 (73.97%)	27.03M
HCTIHealthcare Triangle Inc	$ 1.165 (68.38%)	4.33M
ORISOriental Rise Holdings Ltd	$ 3.6833 (-93.42%)	27.39M
LICNLichen China Limited	$ 0.4895 (-76.91%)	185.72M
MYNAMynaric AG	$ 0.499246 (-64.59%)	3.55M
CEROCERo Therapeutics Holdings Inc	$ 0.1146 (-40.16%)	37.55M
BTCTBTC Digital Ltd	$ 10.50 (-32.95%)	3.25M
SMXSMX Security Matters Public Company	$ 0.4879 (64.06%)	439.45M
SOUNSoundHound AI Inc	$ 15.01 (12.60%)	215.44M
LICNLichen China Limited	$ 0.4895 (-76.91%)	185.72M
NVDANVIDIA Corporation	$ 142.44 (-1.81%)	185.01M
SVMHSRIVARU Holding Ltd	$ 0.0293 (-16.29%)	159.42M